WO2011150375A3 - Endothelial colony forming cell culture medium - Google Patents
Endothelial colony forming cell culture medium Download PDFInfo
- Publication number
- WO2011150375A3 WO2011150375A3 PCT/US2011/038414 US2011038414W WO2011150375A3 WO 2011150375 A3 WO2011150375 A3 WO 2011150375A3 US 2011038414 W US2011038414 W US 2011038414W WO 2011150375 A3 WO2011150375 A3 WO 2011150375A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cell culture
- colony forming
- culture medium
- endothelial colony
- forming cell
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/069—Vascular Endothelial cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/80—Undefined extracts from animals
- C12N2500/84—Undefined extracts from animals from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/165—Vascular endothelial growth factor [VEGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/2306—Interleukin-6 (IL-6)
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Vascular Medicine (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Disclosed herein is cell culture media comprising umbilical cord plasma that is substantially free of serum. The media may be supplemented with one or more growth factors, hrbFGF, hrEGF, hrVEGF165, hrVEGF121, hrSCF, SDFlα, hrIL-6, and any combination thereof. The media may be used to expand cells in culture, such as endothelial colony forming cells, prior to implantation into a patient.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34959910P | 2010-05-28 | 2010-05-28 | |
US61/349,599 | 2010-05-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011150375A2 WO2011150375A2 (en) | 2011-12-01 |
WO2011150375A3 true WO2011150375A3 (en) | 2014-03-20 |
Family
ID=45004877
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2011/038414 WO2011150375A2 (en) | 2010-05-28 | 2011-05-27 | Endothelial colony forming cell culture medium |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2011150375A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20170246218A1 (en) * | 2014-10-06 | 2017-08-31 | Fondazione Irccs Ca' Granda-Ospedale Maggiore Policlinico | Ophthalmic compositions |
CN108486045A (en) * | 2018-01-23 | 2018-09-04 | 广东颜值科技有限公司 | A kind of culture composition of human fibroblasts |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6194207B1 (en) * | 1997-01-31 | 2001-02-27 | Hemosol Inc. | Methods for the selective expansion of lymphocytes by in vitro cultivation |
US20080025956A1 (en) * | 2004-02-09 | 2008-01-31 | Indiana University Research And Technology Corporation | Blood vessel formation from endothelial colony forming cells |
-
2011
- 2011-05-27 WO PCT/US2011/038414 patent/WO2011150375A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6194207B1 (en) * | 1997-01-31 | 2001-02-27 | Hemosol Inc. | Methods for the selective expansion of lymphocytes by in vitro cultivation |
US20080025956A1 (en) * | 2004-02-09 | 2008-01-31 | Indiana University Research And Technology Corporation | Blood vessel formation from endothelial colony forming cells |
Also Published As
Publication number | Publication date |
---|---|
WO2011150375A2 (en) | 2011-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2011133902A3 (en) | Cell culture medium comprising small peptides | |
WO2012135621A3 (en) | Priming of pluripotent stem cells for neural differentiation | |
ZA201206635B (en) | Cell culture medium for the growth and differentiation of cells of the hematopoietic lineage | |
WO2008118392A3 (en) | Synthetic cell platforms and methods of use thereof | |
WO2010096588A3 (en) | Cell culture media containing combinations of proteins | |
SG196784A1 (en) | Stem cell cultures | |
WO2012062810A3 (en) | Cell culture medium and process for protein expression, said medium and process comprising a pam inhibitor | |
JP2014501518A5 (en) | ||
CA2863795A1 (en) | Culturing of mesenchymal stem cells | |
WO2012168743A3 (en) | Electrogenic bacteria with heterologous mtr or omc genes | |
MX2012000110A (en) | Method of producing erythrocytes without feeder cells. | |
WO2007136936A3 (en) | Dermis-derived cells for tissue engineering applications | |
WO2010148203A3 (en) | Producer cells for replication competent retroviral vectors | |
WO2010075504A3 (en) | Engineered microorganisms for the production of one or more target compounds | |
WO2012048010A3 (en) | Compositions of adult organ stem cells and uses thereof | |
EP2995677A4 (en) | Culture medium composition for improving regenerative capacity of stem cells, and stem cell culturing method using same | |
WO2011160128A3 (en) | Cardiomyocyte medium with dialyzed serum | |
WO2016071505A9 (en) | Microbial production of the flavonoids garbanzol, resokaempferol and fisetin | |
WO2013039776A8 (en) | Methods of hydrolyzing and fermenting cellulosic material | |
WO2010130306A8 (en) | Bioreactorsystem | |
WO2011112601A3 (en) | Continuous flow bioreactor for magnetically stabilized three-dimensional tissue culture | |
WO2011028264A3 (en) | Methods and systems involving materials and electrodes for water electrolysis and other electrochemical techniques | |
WO2012046065A3 (en) | Culture method for culturing pluripotent cells comprising an inhibitor of mirna- 181a* | |
WO2011150375A3 (en) | Endothelial colony forming cell culture medium | |
WO2012126013A3 (en) | Method for making pluripotent stem cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11787526 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11787526 Country of ref document: EP Kind code of ref document: A2 |